Funding for this research was provided by:
World Cancer Research Fund International (2004/03)
Fifth Framework Programme (QLK4-1999-01422)
Medical Research Council (G1001995, 7500001180, U106179472, MC_UU_12015/2, MC_UU_00006/2)
Newlife – The Charity for Disabled Children (07/20)
Mothercare Charitable Foundation (RG54608)
National Institute for Health Research Cambridge Biomedical Research Centre
Article History
Received: 9 February 2022
Accepted: 20 April 2022
First Online: 4 May 2022
Declarations
:
: Ethical approval for the Cambridge Baby Growth Study was granted by the Cambridge Local Research Ethics Committee, Addenbrooke’s Hospital, Cambridge, U.K. (00/325). All procedures followed were in accordance with both institutional and international guidelines. Written informed consent was obtained from all women (on their own behalf and on behalf of their baby).
: Not applicable.
: The authors declare that they have no competing interests.